Over the last few years, scientists and entrepreneurs have flocked to developing medicines that target RNA, the genetic ...

Yale researchers have developed a new and safe family of RNA-editing tools that utilize an RNA-targeting activity that they ...

Dawnzera is the first and so far only RNA-targeting therapy approved as a prophylactic treatment for hereditary angioedema ...

Dawnzera is the first and only RNA-targeted prophylactic therapy to be approved for hereditary angioedema in adults and ...

In June, the monoclonal antibody garadacimab (Andembry) was approved for prevention of HAE attacks at a dose of once monthly ...

A new study suggests an enzyme unique to Homo sapiens may have made us more competitive water seekers than our closest ...

In 1957, just four years after Francis Crick and other scientists solved the riddle of DNA’s structure—the now famous double ...

The approval makes donidalorsen the only treatment in the US for hereditary angioedema that is an RNA-targeted prophylactic.

In the past decade, there has been significant interest in studying the expression of our genetic code down to the level of ...

As aging progresses, the quality of DNA and proteins inside cells declines, which is known to be the cause of various ...

Single-cell proteomics with RNA sequencing uncover hidden gene expression dynamics in stem cell differentiation.

The collaboration will explore RNA-based small molecule drug candidates aimed at neurological conditions where existing ...